Back To Index  <<  Back To Templates

ref Template  BC Medication Identification

Id 2.16.840.1.113883.3.1818.10.4.16 Effective Date valid from 2017‑03‑30 23:55:59
Status draft Draft Version Label
Name BCMedicationIdentification Display Name BC Medication Identification
Description

The Medication Identification List template defines the structure to identify the specific drug and drug strength that is the subject of the Medication List record as defined in the Medication Observation template.

CDA Extensions

This template includes the following CDA Extensions:

  •   Drug Description: The Drug Description (LabeledDrug/e2e:desc)has been added to the schema to support a free form textual description of the drug. This is usually only populated for custom compounds, providing instructions on the composition and creation of the compound.

  •   Drug Form: The Drug Form (LabeledDrug/e2e:formCode) has been added to the schema communicate the administration form of the drug (e.g. tablet, capsule, powder, etc.).

  •   Drug Ingredient: Frequently the drug strength is assumed to be included in or implied by the drug code itself. For example, there is a specific DIN code for TYLENOL 325 mg tablet (00723894). However, the specification supports the communication of the drug strength attribute as a separate element to accommodate historical or patient reported data that may not be coded or may not have the strength pre-coordinated in the drug code or implied through the drug name. 


    1. Generic Name

      The Generic Name is used to communicate the generic ingredients that are included in the drug. This is included as the <translation> component of the Drug Code element which may repeat.

      In some cases there will be multiple generic named ingredients within the drug; for example, Tylenol 3 has acetaminophen 300mg and codeine 30mg and caffeine as generic ingredients. This element is a string format and there are no requirements for the display of the ingredient name, strength and units of measure; however, it is strongly recommended that the element repeat with each ingredient included in its own repetition. Having this recorded as a single text string causes difficulties for calculating defined daily dose when a medication formulation consists of a combination of different drugs.

      This field may be absent if a DIN code is provided as the receiving system may use the DIN code to identify the component generic ingredients.

      Drug Description

      The Drug Description is a free form textual description of the drug. This usually is only populated for custom compounds, providing instructions on the composition and creation of the compound.

      This field may also be used to provide more detailed and supplemental information regarding the Drug; however, dispensing and administration instructions should not be included here as there are specific instruction fields for that information. 

Classification CDA Entry Level Template
Open/Closed Closed (only defined elements are allowed)
Used by / Uses
Used by 12 templates, Uses 1 template
Used by Template id as Name Version
2.16.840.1.113883.3.1818.10.3.18 Containment draft BC Medication Event 2017‑04‑03 02:55:58
2.16.840.1.113883.3.1818.10.2.19.1 link draft BC CDA E2E Medication List with Entries 2017‑04‑03 06:34:17
2.16.840.1.113883.3.1818.10.1.1 link draft BC CDA E2E EMR Conversion 2016‑11‑18 18:04:46
2.16.840.1.113883.3.1818.10.1.2 link draft BC CDA E2E Generic Episodic Document 2017‑04‑04 13:48:26
2.16.840.1.113883.3.1818.10.1.2 link draft BC CDA E2E Generic Episodic Document 2017‑04‑04 13:39:16
2.16.840.1.113883.3.1818.10.1.3 link draft BC CDA E2E Patient Chart Transfer 2017‑04‑04 12:36:54
2.16.840.1.113883.3.1818.10.2.9.1 link draft BC CDA E2E Current Medications with Entries 2017‑04‑03 05:41:18
2.16.840.1.113883.3.1818.10.1.6 link draft BC CDA E2E Structured Referral 2017‑04‑04 15:16:39
2.16.840.1.113883.3.1818.10.1.7 link draft BC CDA E2E Structured Consult Report 2017‑04‑04 13:59:01
2.16.840.1.113883.3.1818.10.4.20 Containment draft BC Medication Prescription Event 2017‑04‑01 07:08:11
2.16.840.1.113883.3.1818.10.4.7 Containment draft BC Medication Dispense Event 2017‑04‑01 05:33:20
2.16.840.1.113883.3.1818.10.4.8 Containment draft BC Dose Observation 2017‑03‑31 00:24:47
Uses Template id as Name Version
2.16.840.1.113883.3.1937.777.17.10.10 Include draft BC LabeledDrug DYNAMIC
Relationship Specialization: template 2.16.840.1.113883.10.12.312 (2005‑09‑07)
Item DT Card Conf Description Label
hl7:manufacturedProduct
1 … 1 R CONF‑1553
treetree @classCode
cs 1 … 1 F MANU CONF‑1554
Choice 1 … 1 Elements to choose from:
Included 0 … 1 R from 2.16.840.1.113883.3.1937.777.17.10.10 BC LabeledDrug (DYNAMIC)
treeblank treetree hl7:manufacturedLabeledDrug
0 … 1 R CONF‑1555
treeblank treeblank treetree @classCode
cs 1 … 1 F MMAT CONF‑1556
treeblank treeblank treetree @determinerCode
cs 1 … 1 F KIND CONF‑1557
treeblank treeblank treetree hl7:code
CE CWE 1 … 1 R CONF‑1558
  Constraint
  1. SHALL be selected from ValueSet ClinicalDrug 2.16.840.1.113883.2.20.3.29 DYNAMIC [CONF:1558]. 

treeblank treeblank treetree hl7:name
EN 1 … 1 R CONF‑1559
treeblank treeblank treetree e2e:desc
ED 0 … 1 CONF‑1560
treeblank treeblank treetree e2e:formCode
CD CWE 0 … 1 CONF‑1561
treeblank treeblank treetree e2e:ingredient
0 … 50 CONF‑4325
treeblank treeblank treeblank treetree @classCode
cs 1 … 1 F INGR CONF‑4326
treeblank treeblank treeblank treetree e2e:quantity
PQ 0 … 1 R CONF‑4327
treeblank treeblank treeblank treetree e2e:ingredient
1 … 1 R CONF‑4328
treeblank treeblank treeblank treeblank treetree @classCode
cs 1 … 1 F MMAT CONF‑4329
treeblank treeblank treeblank treeblank treetree @determinerCode
cs 1 … 1 F KIND CONF‑4330
treeblank treeblank treeblank treeblank treetree e2e:code
CD 0 … 1 CONF‑4331
  Constraint

SHALL be selected from ValueSet ClinicalDrug 2.16.840.1.113883.2.20.3.29 DYNAMIC (CDA R2 Extension) [CONF:4331]. 

treeblank treeblank treeblank treeblank treetree e2e:name
ED 0 … 1 CONF‑4332